Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Study Participants and Recruitment
2.3. iCARE Survey Questionnaire
2.4. Data Analysis
3. Results
3.1. Sample Description
3.2. Sociodemographic Differences as a Function of Booster Vaccination Status
3.3. Motivators for Getting the COVID-19 Booster Vaccine
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- West, R.; Michie, S.; Rubin, G.J.; Amlôt, R. Applying principles of behaviour change to reduce SARS-CoV-2 transmission. Nat. Hum. Behav. 2020, 4, 451–459. [Google Scholar] [CrossRef] [PubMed]
- Government of Canada, Statistics Canada. COVID-19: Effectiveness and Benefits of Vaccination. Available online: https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines/effectiveness-benefits-vaccination.html (accessed on 22 June 2022).
- WHO. Strategic Advisory Group of Experts on Immunization Updates Recommendations on Boosters, COVID-19 Vaccines for Children—PAHO/WHO | Pan American Health Organization (n.d.). Available online: https://www.paho.org/en/news/21-1-2022-who-strategic-advisory-group-experts-immunization-updates-recommendations-boosters (accessed on 14 December 2022).
- Levine-Tiefenbrun, M.; Yelin, I.; Alapi, H.; Herzel, E.; Kuint, J.; Chodick, G.; Gazit, S.; Patalon, T.; Kishony, R. Waning of SARS-CoV-2 booster viral-load reduction effectiveness. Nat. Commun. 2022, 13, 1–4. [Google Scholar]
- Coppeta, L.; Ferrari, C.; Somma, G.; Mazza, A.; D’Ancona, U.; Marcuccilli, F.; Grelli, S.; Aurilio, M.T.; Pietroiusti, A.; Magrini, A.; et al. Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine. Vaccines 2022, 10, 141. [Google Scholar] [CrossRef]
- Loubet, P.; Laureillard, D.; Martin, A.; Larcher, R.; Sotto, A. Why promoting a COVID-19 vaccine booster dose? Anaesth. Crit. Care Pain Med. 2021, 40, 100967. [Google Scholar] [CrossRef]
- Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 22 June 2022).
- MacDonald, N.E.; Eskola, J.; Liang, X.; Chaudhuri, M.; Dube, E.; Gellin, B.; Goldstein, S.; Larson, H.; Manzo, M.L.; Reingold, A.; et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
- Dettori, M.; Arghittu, A.; Castiglia, P. Knowledge and Behaviours towards Immunisation Programmes: Vaccine Hesitancy during the COVID-19 Pandemic Era. Int. J. Environ. Res. Public Health 2022, 19, 4359. [Google Scholar] [CrossRef]
- Public Health Agency of Canada. Demographics: COVID-19 Vaccination Coverage in Canada-Canada.ca. Available online: https://health-infobase.canada.ca/covid-19/vaccination-coverage/ (accessed on 14 December 2022).
- Al-Qerem, W.; Al Bawab, A.Q.; Hammad, A.; Ling, J.; Alasmari, F. Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study. Vaccines 2022, 10, 410. [Google Scholar] [CrossRef]
- Hagger, M.S.; Hamilton, K. Predicting COVID-19 booster vaccine intentions. Appl. Psychology. Health Well-Being 2022, 14, 819–841. [Google Scholar] [CrossRef]
- Ben-David, B.M.; Keisari, S.; Palgi, Y. Vaccine and Psychological Booster: Factors Associated With Older Adults’ Compliance to the Booster COVID-19 Vaccine in Israel. J. Appl. Gerontol. 2022, 41, 1636–1640. [Google Scholar] [CrossRef]
- Bacon, S.L.; Lavoie, K.L.; Boyle, J.; Stojanovic, J.; Joyal-Desmarais, K. International assessment of the link between COVID-19 related attitudes, concerns and behaviours in relation to public health policies: Optimising policy strategies to improve health, economic and quality of life outcomes (the iCARE Study). BMJ open 2021, 11, e046127. [Google Scholar] [CrossRef]
- Taylor, S.; Landry, C.A.; Paluszek, M.M.; Groenewoud, R.; Rachor, G.S.; Asmundson, G.J. A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2. Front. Psychol. 2020, 11, 575950. [Google Scholar] [CrossRef] [PubMed]
- Yaqub, O.; Castle-Clarke, S.; Sevdalis, N.; Chataway, J. Attitudes to vaccination: A critical review. Soc. Sci. Med. 2014, 112, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Mehraeen, E.; Karimi, A.; Barzegary, A.; Vahedi, F.; Afsahi, A.M.; Dadras, O.; Moradmand-Badie, B.; Seyed Alinaghi, S.A.; Jahanfar, S. Predictors of mortality in patients with COVID-19-a systematic review. Eur. J. Integr. Med. 2020, 40, 101226. [Google Scholar] [CrossRef]
- Bajgain, K.T.; Badal, S.; Bajgain, B.B.; Santana, M.J. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am. J. Infect. Control. 2021, 49, 238–246. [Google Scholar] [CrossRef] [PubMed]
- Oglesby, M.E.; Schmidt, N.B. The role of threat level and intolerance of uncertainty (IU) in anxiety: An experimental test of IU theory. Behavior Therapy 2017, 48, 427–434. [Google Scholar] [CrossRef]
- Ferreri, F.; Lapp, L.K.; Peretti, C.S. Current research on cognitive aspects of anxiety disorders. Curr. Opin. Psychiatry 2011, 24, 49–54. [Google Scholar] [CrossRef]
- Birrell, J.; Meares, K.; Wilkinson, A.; Freeston, M. Toward a definition of intolerance of uncertainty: A review of factor analytical studies of the intolerance of uncertainty scale. Clin. Psychol. Review 2011, 31, 1198–1208. [Google Scholar] [CrossRef]
- Lavail, K.H.; Kennedy, A.M. The Role of Attitudes About Vaccine Safety, Efficacy, and Value in Explaining Parents’ Reported Vaccination Behavior. Health Educ. Behav. 2013, 40, 544–551. [Google Scholar] [CrossRef]
- Szilagyi, P.G.; Shah, M.D.; Delgado, J.R.; Thomas, K.; Vizueta, N.; Cui, Y.; Vangala, S.; Shetgiri, R.; Kapteyn, A. Parents’ Intentions and Perceptions About COVID-19 Vaccination for Their Children: Results From a National Survey. Pediatrics 2021, 148, e2021052335. [Google Scholar] [CrossRef]
- Public Health Agency of Canada. Vaccination Hesitancy among Canadian Parents. Available online: https://www.canada.ca/fr/sante-publique/services/publications/vie-saine/hesitation-vaccination-parents-canadiens.html (accessed on 6 April 2022).
- Rosenstock, I.M. The Health Belief Model and Preventive Health Behavior. Health Educ. Monogr. 1974, 2, 354–386. [Google Scholar] [CrossRef]
- Joshi, A.; Kaur, M.; Kaur, R.; Grover, A.; Nash, D.; El-Mohandes, A. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front. Public Health 2021, 9, 698111. [Google Scholar] [CrossRef] [PubMed]
- Deslauriers, F.; Léger, C.; Bacon, S.L.; Lavoie, K.L. International prevalence and motivators for getting COVID-19 booster vaccines: Results from the iCARE study in Australia Italy and Colombia. In Proceedings of the American Psychosomatic Society 80th Annual Scientific Meeting 2023, San Juan, Puerto Rico, 8–11 March 2023. [Google Scholar]
- WHO. COVID-19 Vaccines: Everything You Need to Know. Available online: https://www.gavi.org/covid19-vaccines (accessed on 14 December 2022).
Not Boosted | Boosted | ||
---|---|---|---|
(N = 859) | (N = 1744) | ||
Descriptive characteristics variables | % (n) | % (n) | pa |
Sex | |||
Man | 48.9 (419) | 46.9 (813) | 0.323 |
Woman | 51.1 (437) | 53.1 (921) | |
Missing values | 410 | ||
Age | |||
Less than or equal to 25 years | 18.7 (159) | 9.5 (164) | <0.001 |
26–50 years | 53.4 (455) | 30.0 (522) | |
51 years or more | 27.9 (238) | 60.5 (1051) | |
Missing values | 412 | ||
Education level | |||
High school diploma or less | 74.0 (633) | 71.1 (1231) | 0.132 |
College or more | 26.0 (223) | 28.9 (500) | |
Missing values | 415 | ||
Income | |||
Less than 60K/year | 47.6 (365) | 43.7 (682) | 0.075 |
60K/year or more | 52.4 (401) | 56.3 (877) | |
Missing values | 676 | ||
Chronic disease | |||
No chronic disease | 63.5 (529) | 49.0 (836) | <0.001 |
At least one chronic disease | 36.5 (304) | 51.0 (870) | |
Missing values | 462 | ||
Presence of any depressive disorder | |||
Yes | 21.1 (175) | 15.9 (273) | 0.001 |
No | 78.9 (651) | 84.1 (1448) | |
Missing values | 454 | ||
Presence of any anxiety disorder | |||
Yes | 26.8 (223) | 20.3 (347) | 0.001 |
No | 73.2 (610) | 79.7 (1363) | |
Missing values | 458 | ||
Parent | |||
Not a parent | 71.7 (601) | 84.1 (1444) | <0.001 |
Parent | 28.3 (238) | 15.9 (272) | |
Missing values | 447 | ||
Known or thought to have been infected with COVID-19 | |||
Yes | 70.9 (227) | 84.8 (248) | <0.001 |
No | 29.1 (552) | 15.2 (1383) | |
Missing values | 591 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Léger, C.; Deslauriers, F.; Gosselin Boucher, V.; Phillips, M.; Bacon, S.L.; Lavoie, K.L. Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study. Vaccines 2023, 11, 291. https://doi.org/10.3390/vaccines11020291
Léger C, Deslauriers F, Gosselin Boucher V, Phillips M, Bacon SL, Lavoie KL. Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study. Vaccines. 2023; 11(2):291. https://doi.org/10.3390/vaccines11020291
Chicago/Turabian StyleLéger, Camille, Frédérique Deslauriers, Vincent Gosselin Boucher, Meghane Phillips, Simon L. Bacon, and Kim L. Lavoie. 2023. "Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study" Vaccines 11, no. 2: 291. https://doi.org/10.3390/vaccines11020291
APA StyleLéger, C., Deslauriers, F., Gosselin Boucher, V., Phillips, M., Bacon, S. L., & Lavoie, K. L. (2023). Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study. Vaccines, 11(2), 291. https://doi.org/10.3390/vaccines11020291